A number of biomarkers for endothelial damage have been identified, including glycocalyx [29], soluble thrombomodulin [30], and antiopoietin-2 [31], and these biomarkers may also serve as adjunctive therapeutic targets with the aim of restoring endothelial function and avoiding fluid overload in patients with sepsis. Here, THBD is linked to Sepsis.